✦ LIBER ✦

P80 Serum markers of response in a neo-adjuvant clinical trial of the IGF-IR mabA12 in prostate cancer

✍ Scribed by S. Plymate; P. Cohen; J. Dean; D. Lin; J. Corman; D.L. Ludwig; R.B. Montgomery

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-110 The challenges of using radiologic

✍ L. Hiller; N. Fenwick; A.L. Vallier; J.A. Dunn; S. Hilborne; L. Jones; J. Abraha 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Paradoxical metastatic progression follo

✍ Denham, James W.; Steigler, Allison; Tai, Keen-Hun; Joseph, David; Matthews, Joh 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 360 KB

5BA Clinical validation of in vitro drug

✍ H. Bonnefoi; A. Potti; L. Mauriac; M. Tubiana-Hulin; M. Campone; D. Cameron; J. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 40 KB

565 POSTER Activity of the anti-IGF-IR a

✍ J.S. De Bono; D.P. Petrylak; E. Calvo; F. Saad; G.R. Hudes; M.M. Cooney; M.N. Po 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Subcutaneous versus intravenous administ

✍ Gustavo Ismael; Roberto Hegg; Susanne Muehlbauer; Dominik Heinzmann; Bert Lum; S 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 245 KB

The effect of short term neo-adjuvant an

✍ Patricia E. Daly; Mary T. Dunne; Carmel M. O’Shea; Marie A. Finn; John G. Armstr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 273 KB